DLX3
- 1 lab in 1 country
- Funders: National Institute of Dental and Craniofacial Research and 2 more
- Cells1
Effects
2Cellular senescence
downin human cells1downin mouse cells1
1 study
Cellular senescence
downin human cells1downin mouse cells1
DLX3 decreases cellular senescence in mouse cells.
“Both DLX3 mutations (c.533 A>G and c.571_574delGGGG) delayed cellular senescence when they were introduced into pre-osteoblastic cells MC3T3-E1.”
Cellsc.533 A>G and c.571_574delGGGG in MC3T3-E1 cells
Scientific reports
DLX3 decreases cellular senescence in human cells.
“DLX3 mutation (c.533 A>G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal stem cells (BMSCs) isolated from a TDO patient”
CellsBMSCs isolated from a TDO patient
Scientific reports
Bone loss
downin mice1
1 study
Bone loss
downin mice1
DLX3 prevents bone loss in mice.
“DLX3 (Q178R) transgenic mice not only reconfirmed that DLX3 mutation (Q178R) delayed cellular senescence, but also prevented aging-mediated bone loss.”
Animalsaging-mediated bone loss in transgenic mice
Scientific reports
Latest
Scientific Reports
Senescence: novel insight into DLX3 mutations leading to enhanced bone formation in Tricho-Dento-Osseous syndrome
Experiments in human cellsCellular senescence